Highlights
Scientific presentation:
Empowering precision oncology - Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.
Scientific presentation:
Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease
Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA.
Scientific presentation:
PET amyloid imaging in clinical trials
Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Scientific presentation:
The exploration of ultra-low dose PET/CT and its implications for patient care
Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA.
Scientific presentation:
A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics
Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA.
Scientific presentation:
Empowering precision oncology - Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.
Scientific presentation:
Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease
Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA.
Scientific presentation:
PET amyloid imaging in clinical trials
Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Scientific presentation:
The exploration of ultra-low dose PET/CT and its implications for patient care
Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA.
Scientific presentation:
A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics
Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA.
Scientific presentation:
Empowering precision oncology - Expanding access to next-generation theranostics
Joseph R. Osborne, MD, PhD; Chief, Division of Molecular Imaging and Therapeutics, Professor of Radiology, Weill Cornell Medicine, New York, New York.